Rex Wiggins (@RexWigginsnf80) profile picture

Career Venture Capitalist.

Joined March 2026
Photo by Rex Wiggins (@RexWigginsnf80)Photo by Rex Wiggins (@RexWigginsnf80)Photo by Rex Wiggins (@RexWigginsnf80)Photo by Rex Wiggins (@RexWigginsnf80)Photo by Rex Wiggins (@RexWigginsnf80)Photo by Rex Wiggins (@RexWigginsnf80)Photo by Rex Wiggins (@RexWigginsnf80)Photo by Rex Wiggins (@RexWigginsnf80)Photo by Rex Wiggins (@RexWigginsnf80)Photo by Rex Wiggins (@RexWigginsnf80)
I own all 3 $GTBIF $MSOS $MSOX 🚀🚀
Friendly reminder $GTBIF now trading at 3.7x 2027 EBITDA $MSOS $MSOX
3
267
Once Doug is talking his book you are already on the wrong side of the trade.
2
1
6
1,170
Rex Wiggins retweeted
Ignoring news as usual, im eyeing the bounce at 3.5 to play 15-20% to 4.00-4.20 $msos
1
10
532
Rex Wiggins retweeted
So $GLAS greenhouse and equipment minus debt at discounted blow out price is equal to market cap… buying
1
7
816
Rex Wiggins retweeted
There is a reason why @Trulieve is the #1 stock in the largest ETF in the USA cannabis space $MSOS , it represents 40% of the #1 ETF..look at the growth @NYSE listed, connected CEO @rivers_kim , making moves in TEXAS and GEORGIA, with a DOMINANT market position in FLORIDA $TRLV
3
19
1,009
Rex Wiggins retweeted
$MSOS 😁
$GLAS no negative early PR looks like a possible 30%++ plus day 😁
1
8
684
Rex Wiggins retweeted
Russel 2000 and 3000 index inclusion Another incredible milestone after years of suffering on the OTC/pink sheets Congrats @rivers_kim $TRLV $MSOS $MSOX
Trulieve Announces Preliminary Addition to the Russell 2000® and 3000® Indices $TRLV investors.trulieve.com/2026-…
2
1
28
1,065
$GLAS Q3 earnings highlight record scale, falling production costs, and major regulatory advantages: • Record Output & Lower Costs: Q3 biomass production hit a record 319,052 lbs (+29.8% QoQ), while production cost dropped to $109/lb (down from $122 in Q2). Reaffirmed full-year ~1M lbs production guidance and $95/lb long-term cost target. • Schedule III & DEA Ready: Already registered with the DEA and operating fully medical-licensed under a Schedule III designation. • Global Commerce Milestone: Earned GACP certifications for its Casitas and Padaro farms — a critical step toward unlocking interstate and international medical cannabis trade.
3
737
Trulieve Announces Preliminary Addition to the Russell 2000® and 3000® Indices $TRLV investors.trulieve.com/2026-…
8
538
Agree never trust a HF. $MSOS
Replying to @DougKass
It's funny how u don't say here that u were recommending $MSOS for much of this year as well as $GLAS (a fraud). None of what u say here is new yet u are pretending that u are somehow advising people to avoid now because of the risks. Don't talk accountability anymore!!😂😂😂
3
460
Rex Wiggins retweeted
🏖️ Trulieve Cannabis @Trulieve @Trulieve_IR (NYSE: $TRLV) is already drawing passive money from broad U.S. market and small-cap index products after its historic NYSE listing and S&P inclusion. 🚨 Tonight, after the close, investors find out whether the pure-play medical cannabis operator joins the Russell 2000 — potentially unlocking a new wave of mandatory buying in a sector still dominated by OTC trading and waiting on fuller federal normalization. Trulieve, the first major plant-touching U.S. cannabis multi-state operator to list on the NYSE (June 2026) after medical marijuana’s rescheduling to Schedule III, was added in September to the S&P Total Market Index, S&P Completion Index, and related health-care sub-indices. That opened the door to passive ownership by funds tracking those benchmarks. Index funds and ETFs already holding ~$60M TRLV Holdings data show a mix of thematic cannabis vehicles and passive broad-market/small-cap products: - AdvisorShares Pure US Cannabis ETF ($MSOS): The largest disclosed holder, with roughly 15% of TRLV’s shares outstanding and a ~23% weighting in the fund itself (MSOS AUM in the high hundreds of millions). This is active/thematic exposure rather than pure index tracking. - Vanguard Extended Market ETF ($VXF) and Vanguard Total Stock Market ETF (VTI): Direct beneficiaries of the S&P Completion and Total Market additions; together they account for a meaningful slice of the passive ownership. - Schwab U.S. Small-Cap ETF ($SCHA) and Schwab U.S. Broad Market ETF ($SCHB) - iShares Core S&P Total U.S. Stock Market ETF ($ITOT) - First Trust small-cap AlphaDEX funds ($FYC, $FYX) and a handful of smaller or multi-cap products. Collectively, tracked ETFs report ownership in the high teens percent of shares (hundreds of millions in value), with Vanguard products alone representing about 2%. These positions largely stem from the post-NYSE/S&P eligibility rather than Russell membership. Pure Russell 2000 trackers such as the iShares Russell 2000 ETF ($IWM, ~$77–78 billion AUM) and Vanguard’s Russell 2000 vehicle ($VTWO) do not yet hold TRLV at scale because it is not currently a constituent. How to find out today after the close FTSE Russell’s December 2026 reconstitution schedule is clear: Rank Day was October 30. Preliminary additions and deletions are published after the U.S. market close today, Friday, November 13. A query period follows (roughly November 16–27), with updates and a lockdown later in the month. Changes take effect after the close on December 11, with markets opening December 14 under the new membership. Check the FTSE Russell / LSEG site (russell-reconstitution resources and notices), major newswires, or company channels after 4 p.m. ET. Some quantitative shops and specialist commentators have flagged TRLV as having cleared the key screens (exchange listing, U.S. domicile after Delaware domestication, float, size, etc.), but the official preliminary list is the confirmation. Estimates from those analyses suggest that full inclusion could require index funds to buy on the order of 10–15 million shares around the reconstitution window—material relative to typical daily volume.[](>) Why this matters for cannabis Most of the cannabis sector still trades on the OTC with limited institutional participation. Federal Schedule I status historically created custody, banking, exchange-listing, and mandate barriers; even after Schedule III rescheduling enabled NYSE listing and S&P eligibility for pure medical operators like Trulieve (which spun out mixed-use assets), many institutions remain cautious pending further clarity on banking (e.g., SAFER-type legislation), adult-use policy, and tax treatment. Index inclusion changes the calculus: • Forced buying: Assets benchmarked to the Russell 2000 ($IWM alone is ~$77–78B; total tracking assets are substantially larger across ETFs and mutual funds) must own the stock in proportion to its index weight once it is added. That creates non-discretionary demand and improved liquidity. • Visibility and cost of capital: Higher trading volume, tighter spreads, and broader ownership can lower the cost of equity and make the stock more investable for managers who previously could not or would not touch OTC cannabis names. • Template effect: As the top holding in $MSOS and a scaled medical operator with strong Florida and other state positions, strong cash generation, and recent DEA registration progress, $TRLV ’s path (NYSE + S&P + potential Russell) is being watched as a blueprint for other larger MSOs once they clear similar eligibility hurdles. • Still early: Even with Schedule III, the sector has not yet seen full institutionalization. Index buying is a meaningful incremental step while the industry continues to wait for broader rescheduling effects, banking access, and clearer federal frameworks. It does not remove operational or regulatory risks, but it does expand the buyer base beyond retail and specialized cannabis funds. In short, today’s after-close preliminary list is the next concrete data point in cannabis’s gradual move from OTC niche to mainstream small-cap index eligibility. Confirmation of Russell 2000 addition would mark another milestone in that process; absence would simply mean the company remains outside that particular passive bucket for now while it continues to benefit from the S&P Total Market/Completion ownership already in place. 🇺🇸🌿🧺 $MSOS
3
6
3
27
9,646
Rex Wiggins retweeted
"From the discussions that I've heard around 🏜️ TEXAS, I feel like we're moving more towards a legalization program. Also, from talking to hearing the politicians talk, it's not that they want the program that they had in there with hemp and moving all that stuff along. It's now people are talking about how do we get appropriate regulations in place so that marijuana is legal in the state. Okay, and if that happens, Texas will become one of the largest legal markets in the United States." — Michael Bronstein @BronsteinSpeaks, President of @ATACHorg "It's moving away from Hemp [vs] Cannabis to more like regulated THC." — Shadd Dales @shadddales "That's what I said at the beginning. They didn't need to do the ban. Just spin up an adult use market, regulate everybody, and let the free market decide who the winners are going to be. It'd be a pretty simple exercise. — Anthony Varrell @V_arrell 🎦 WATCH the full interview: youtube.com/live/yc-_WsOqm8E… 🇺🇸🌿🧺 $MSOS
4
6
25
3,109
Rex Wiggins retweeted
📟 Paging ⚖️ ALJ Derek Julius... 🇺🇸🌿🧺 $MSOS
9
5
47
2,649
Let the Games Begin The year-end cannabis battle is upon us. #CannabisConfidential 🇺🇸🌿 /position+ $MSOS toddharrison.substack.com/p/…
194
Rex Wiggins retweeted
$MSOS So many positive developments have been stacking yet price remains supressed 1. Stay lifted 2. Medical S3 3. Hemp ban 4. Blue wave, both state and federal 5. Record sales in October. Plus more uncertain stuff like SAFE. Plenty of powder, need the light to set it off.
5
7
3
36
2,660